Who
Adam H. Zaeske
Chief Commercial Officer
Company insider
Files Form 4 as: Chief Commercial Officer, Harmony Biosciences Holdings.
In numbers
- Trades disclosed
- 12
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 7 Apr 2025
- Last trade
- 7 Apr 2026
- Last filed
- 9 Apr 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Apr 2026filed 9 Apr 2026 | HRMY Harmony Biosciences HoldingsPharmaceuticals | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 7 Apr 2026filed 9 Apr 2026 | HRMY Harmony Biosciences HoldingsPharmaceuticals | SEC FORM 4 Code F | $88K3,173 at $27.62 | filing |
| 7 Apr 2026filed 9 Apr 2026 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 7 Apr 2026filed 9 Apr 2026 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 7 Apr 2026filed 9 Apr 2026 | HRMY Harmony Biosciences HoldingsPharmaceuticals | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 7 Apr 2026filed 9 Apr 2026 | HRMY Harmony Biosciences HoldingsPharmaceuticals | SEC FORM 4 Code F | $88K3,173 at $27.62 | filing |
| 22 Jan 2026filed 26 Jan 2026 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —56,900 at $0.00 | filing |
| 22 Jan 2026filed 26 Jan 2026 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —16,200 at $0.00 | filing |
| 22 Jan 2026filed 26 Jan 2026 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —56,900 at $0.00 | filing |
| 22 Jan 2026filed 26 Jan 2026 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —16,200 at $0.00 | filing |
| 7 Apr 2025filed 16 Apr 2025 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 7 Apr 2025filed 16 Apr 2025 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.